OC
Octagon Capital Advisors LP
NEW YORK NY · SEC CIK 0001839435
$1.11B2026Q2 reported value
27Positions
78.5%Top 10 weight · largest 16.1%
5 / 7New / sold out
26Q126Q2
Top 10 holdings % of portfolio
2026Q2 top buys estimated at quarter-end value
ABVX Added+$42.11M
DFTX Added+$23.99M
SMMT New+$18.21M
ANL New+$10.75M
PHVS Added+$10.09M
2026Q2 top sells estimated at quarter-end value
CENTESSA PHARMAC Sold out-$29.79M
KALVISTA PHARMAC Sold out-$29.19M
TERNS PHARMACEUT Sold out-$27.94M
TRVI Reduced-$21.82M
KYMR Reduced-$13.19M
2026Q2 holdings click a header to sort
Export CSV 🔒| Ticker | Name | Value ▼ | Weight | Shares | Share change | Change | Est. flow | Action |
|---|---|---|---|---|---|---|---|---|
| DNTH | DIANTHUS THERAPEUTICS INC | $179.53M | 16.14% | 1,841,667 | -105,000 | -5.4% | -$10.24M | Reduced |
| DFTX | DEFINIUM THERAPEUTICS INC | $138.77M | 12.47% | 2,950,000 | 510,000 | 20.9% | $23.99M | Added |
| ABVX | ABIVAX SA | $132.33M | 11.89% | 993,000 | 316,000 | 46.7% | $42.11M | Added |
| COGT | COGENT BIOSCIENCES INC | $90.94M | 8.17% | 2,350,000 | 0 | 0.0% | — | Unchanged |
| ALMS | ALUMIS INC | $79.66M | 7.16% | 2,830,700 | 0 | 0.0% | — | Unchanged |
| AVBP | ARRIVENT BIOPHARMA INC | $68.47M | 6.15% | 1,971,054 | 0 | 0.0% | — | Unchanged |
| TSHA | TAYSHA GENE THERAPIES INC | $66.01M | 5.93% | 9,693,244 | 833,333 | 9.4% | $5.67M | Added |
| BIOA | BIOAGE LABS INC | $42.84M | 3.85% | 1,748,000 | 0 | 0.0% | — | Unchanged |
| MIRM | MIRUM PHARMACEUTICALS INC | $39.68M | 3.57% | 338,900 | 0 | 0.0% | — | Unchanged |
| KYMR | KYMERA THERAPEUTICS INC | $35.55M | 3.20% | 310,000 | -115,000 | -27.1% | -$13.19M | Reduced |
| AKTS | AKTIS ONCOLOGY INC | $30.97M | 2.78% | 960,847 | 0 | 0.0% | — | Unchanged |
| XENE | XENON PHARMACEUTICALS INC | $29.58M | 2.66% | 490,000 | 0 | 0.0% | — | Unchanged |
| — | ERASCA INC Call | $22.99M | 2.07% | 1,255,000 | 1,255,000 | — | $22.99M | New |
| PALI | PALISADE BIO INC | $21.48M | 1.93% | 10,276,317 | 0 | 0.0% | — | Unchanged |
| OCUL | OCULAR THERAPEUTIX INC | $20.38M | 1.83% | 2,075,000 | -1,091,600 | -34.5% | -$10.72M | Reduced |
| IRON | DISC MEDICINE INC | $19.75M | 1.78% | 270,000 | 0 | 0.0% | — | Unchanged |
| SMMT | SUMMIT THERAPEUTICS INC | $18.21M | 1.64% | 1,250,000 | 1,250,000 | — | $18.21M | New |
| PHVS | PHARVARIS N V | $15.79M | 1.42% | 456,721 | 291,721 | 176.8% | $10.09M | Added |
| ANL | ADLAI NORTYE LTD | $10.75M | 0.97% | 934,716 | 934,716 | — | $10.75M | New |
| DTIL | PRECISION BIOSCIENCES INC | $10.61M | 0.95% | 1,350,000 | -886,732 | -39.6% | -$6.97M | Reduced |
| DBVT | DBV TECHNOLOGIES S A | $9.42M | 0.85% | 574,200 | 0 | 0.0% | — | Unchanged |
| FTH | FAETH THERAPEUTICS INC | $9.03M | 0.81% | 361,010 | 361,010 | — | $9.03M | New |
| — | GYRE THERAPEUTICS INC | $6.29M | 0.57% | 954,416 | 954,416 | — | $6.29M | New |
| TRVI | TREVI THERAPEUTICS INC | $5.87M | 0.53% | 315,000 | -1,170,000 | -78.8% | -$21.82M | Reduced |
| — | UNICYCIVE THERAPEUTICS INC | $4.69M | 0.42% | 1,000,000 | 0 | 0.0% | — | Unchanged |
| — | CONTEXT THERAPEUTICS INC | $1.69M | 0.15% | 3,050,000 | -2,200,000 | -41.9% | -$1.22M | Reduced |
| — | GOSSAMER BIO INC | $1.28M | 0.11% | 7,750,000 | 0 | 0.0% | — | Unchanged |
| — | CENTESSA PHARMACEUTICALS PLC | $0 | 0.00% | 0 | -750,000 | -100.0% | -$29.79M | Sold out |
| — | KALVISTA PHARMACEUTICALS INC | $0 | 0.00% | 0 | -1,450,000 | -100.0% | -$29.19M | Sold out |
| — | TERNS PHARMACEUTICALS INC | $0 | 0.00% | 0 | -530,000 | -100.0% | -$27.94M | Sold out |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | $0 | 0.00% | 0 | -719,000 | -100.0% | -$6.44M | Sold out |
| LXEO | LEXEO THERAPEUTICS INC | $0 | 0.00% | 0 | -1,100,000 | -100.0% | -$6.31M | Sold out |
| CATX | PERSPECTIVE THERAPEUTICS INC | $0 | 0.00% | 0 | -791,555 | -100.0% | -$3.30M | Sold out |
| EVMN | EVOMMUNE INC | $0 | 0.00% | 0 | -143,472 | -100.0% | -$3.30M | Sold out |